Browsing Tag
Carmot Therapeutics
2 posts
Roche’s enicepatide delivers 15.5% weight loss in type 2 diabetes Phase II trial
The once-weekly GLP-1 and GIP medicine also brought blood sugar into the normal range for 62% of patients at its highest dose, supporting plans for broader Phase III development in 2027.
Roche to acquire Carmot Therapeutics to expand obesity treatment portfolio
Roche announced its definitive agreement to acquire Carmot Therapeutics, Inc., based in Berkeley, California, for an upfront purchase…